stockrowLivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +27.0%
- Free cash flow
- −31.0%
- Total debt
- −31.2%
Quarter to September 2026, against a year earlier
Follow LIVN
Alert me
LivaNova PLC (LIVN) Operating cash flow
LivaNova PLC's operating cash flow for fiscal 2025 was $254.3M, up 39.0% from $183.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $237.9M. Over the past ten years it has ranged from −$91.1M (fiscal 2019) to $254.3M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. LivaNova PLC ranks 21st of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $254.3M | 38.95% |
| FY2024 | $183.0M | 144.33% |
| FY2023 | $74.9M | 7.14% |
| FY2022 | $69.9M | (31.81%) |
| FY2021 | $102.5M | — |
| FY2020 | −$79.4M | — |
| FY2019 | −$91.1M | — |
| FY2018 | $120.5M | 31.91% |
| FY2017 | $91.3M | 1.32% |
| FY2016 | $90.2M | 13.15% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $73.7M | 10.63% |
| Jun 2026 | $66.6M | 337.62% |
| Mar 2026 | $15.2M | (81.53%) |
| Dec 2025 | $82.4M | (3.13%) |
| 45 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| HAE Haemonetics Corporation compare | $344.9M |
| BRKR Bruker Corporation compare | $341.8M |
| LIVN LivaNova PLC | $237.9M |
| ITGR Integer Holdings Corporation compare | $176.5M |
| TXG 10x Genomics compare | $127.1M |
| NEOG Neogen Corporation compare | $85.3M |
| IRTC iRhythm Holdings, Inc. compare | $55.6M |
| AXGN AxoGen, Inc. compare | $28.4M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on LIVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement